Dopamine-synthesizing neurons: An overview of their development and application for cell therapy
Author(s):
Abstract:
Cell-gene therapy is a dynamic constituent of novel medical biotechnology. Neurodegenerative disorders in which damage to or demise of specific brain cell types plays central role, are clear examples of disease candidate for cell replacement therapy. Dopaminergic (DAergic) neurons biosynthesize dopamine, a vital neurotransmitter in the central nervous system. Due to the involvement of dopamine in a number of critical physiological functions in human and other mammals, disturbed dopamine neurotransmission resulting from DAergic neuron death or damage causes a few known disorders most prominently Parkinson’s disease (PD). DAergic cell replacement therapies proposed as promising approaches for PD treatment have prompted scientists to thoroughly investigate the embryonic development of DAergic neurons and their function in ordinary life. This review summarizes past and current findings in DAergic neuron development and survival. It also briefly looks at the future prospect of DAergic neuron generation in vitro aiming at clinical applications in vivo.
Language:
English
Published:
Iranian Journal of Biotechnology, Volume:8 Issue: 4, Autumn 2010
Page:
213
magiran.com/p777045
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!